Annual long term liabilities:
$7.65M-$1.96M(-20.39%)Summary
- As of today (July 1, 2025), XENE annual total long term liabilities is $7.65 million, with the most recent change of -$1.96 million (-20.39%) on December 31, 2024.
- During the last 3 years, XENE annual long term liabilities has fallen by -$6000.00 (-0.08%).
- XENE annual long term liabilities is now -75.72% below its all-time high of $31.49 million, reached on December 31, 2012.
Performance
XENE Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$7.29M-$353.00K(-4.62%)Summary
- As of today (July 1, 2025), XENE quarterly total long term liabilities is $7.29 million, with the most recent change of -$353.00 thousand (-4.62%) on March 31, 2025.
- Over the past year, XENE quarterly long term liabilities has dropped by -$1.81 million (-19.87%).
- XENE quarterly long term liabilities is now -54.02% below its all-time high of $15.86 million, reached on March 31, 2019.
Performance
XENE quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
XENE Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -20.4% | -19.9% |
3 y3 years | -0.1% | -11.3% |
5 y5 years | -38.0% | +1248.1% |
XENE Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -23.1% | at low | -30.1% | +1.9% |
5 y | 5-year | -38.0% | +150.7% | -30.1% | +3779.3% |
alltime | all time | -75.7% | >+9999.0% | -54.0% | >+9999.0% |
XENE Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $7.29M(-4.6%) |
Dec 2024 | $7.65M(-20.4%) | $7.65M(-9.0%) |
Sep 2024 | - | $8.40M(-3.2%) |
Jun 2024 | - | $8.68M(-4.6%) |
Mar 2024 | - | $9.10M(-5.2%) |
Dec 2023 | $9.60M(-3.4%) | $9.60M(-1.6%) |
Sep 2023 | - | $9.76M(-5.1%) |
Jun 2023 | - | $10.28M(-1.4%) |
Mar 2023 | - | $10.43M(+4.9%) |
Dec 2022 | $9.95M(+30.0%) | $9.95M(+39.0%) |
Sep 2022 | - | $7.16M(-8.8%) |
Jun 2022 | - | $7.85M(-4.5%) |
Mar 2022 | - | $8.22M(+7.5%) |
Dec 2021 | $7.65M(+150.9%) | $7.65M(+199.1%) |
Sep 2021 | - | $2.56M(-6.8%) |
Jun 2021 | - | $2.75M(-5.4%) |
Mar 2021 | - | $2.90M(-4.9%) |
Dec 2020 | $3.05M(-75.3%) | $3.05M(+1522.3%) |
Sep 2020 | - | $188.00K(-41.8%) |
Jun 2020 | - | $323.00K(-40.3%) |
Mar 2020 | - | $541.00K(-95.6%) |
Dec 2019 | $12.34M | $12.34M(-2.4%) |
Sep 2019 | - | $12.64M(-8.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $13.78M(-13.2%) |
Mar 2019 | - | $15.86M(+5.6%) |
Dec 2018 | $15.01M(+146.0%) | $15.01M(+0.9%) |
Sep 2018 | - | $14.89M(+27.0%) |
Jun 2018 | - | $11.72M(+114.0%) |
Mar 2018 | - | $5.48M(-10.3%) |
Dec 2017 | $6.10M(>+9900.0%) | $6.10M(>+9900.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2016 | - | $86.00K(-14.9%) |
Jun 2016 | - | $101.00K(-13.7%) |
Mar 2016 | - | $117.00K(-12.0%) |
Dec 2015 | $133.00K(-62.3%) | $133.00K(-10.7%) |
Sep 2015 | - | $149.00K(-9.1%) |
Jun 2015 | - | $164.00K(-8.9%) |
Mar 2015 | - | $180.00K(-49.0%) |
Dec 2014 | $353.00K(-97.1%) | $353.00K(-87.5%) |
Sep 2014 | - | $2.82M(-55.7%) |
Jun 2014 | - | $6.38M(-47.6%) |
Dec 2013 | $12.17M(-61.4%) | $12.17M |
Dec 2012 | $31.49M | - |
FAQ
- What is Xenon Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual long term liabilities year-on-year change?
- What is Xenon Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Xenon Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of XENE is $7.65M
What is the all time high annual long term liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual total long term liabilities is $31.49M
What is Xenon Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, XENE annual total long term liabilities has changed by -$1.96M (-20.39%)
What is Xenon Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of XENE is $7.29M
What is the all time high quarterly long term liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly total long term liabilities is $15.86M
What is Xenon Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, XENE quarterly total long term liabilities has changed by -$1.81M (-19.87%)